The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety

Current Urology Reports

Volumn 13, Issue 6, 2012, Pages 447-454

  Glaser, Alexander P ^a   Novakovic, Kristian ^b   Helfand, Brian T ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Anxiety; Complications; Erectile dysfunction; Lower urinary tract symptoms; Prostate biopsy; Prostate cancer

Indexed keywords

ANXIETY; ARTICLE; CARDIOVASCULAR RISK; DEPRESSION; HUMAN; LOWER URINARY TRACT SYMPTOM; MORBIDITY; NERVE BLOCK; PENIS ERECTION; PERIPROSTATIC NERVE BLOCK; PROSTATE BIOPSY; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SATURATION BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; ERECTILE DYSFUNCTION; MALE; NEEDLE BIOPSY; REVIEW;

ANXIETY; BIOPSY, NEEDLE; ERECTILE DYSFUNCTION; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE;

EID: 84877124861     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-012-0277-6     Document Type: Article

References (45)

1. Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 1989;142(1):66-70.
2. Hodge KK, et al. Random systematic vs directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142(1):71-4.
3. Bostwick DG, Meiers I. Prostate biopsy and optimization of cancer yield. Eur Urol. 2006;49(3):415-7.
4. Djavan B, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol. 2001;166:856-60.
5. Raaijmakers R, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60(5):826-30.
6. Berger AP, et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol. 2004;171(4):1478-81.
7. Yu JH, et al. Evaluation of the risk factors for complications after prostate needle biopsy. Eur Urol Suppl. 2010;9(2):84-5.
8. Stewart CS, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001;166(1):91-2.
9. Fleshner N, Klotz L. Role of «saturation biopsy» in the detection of prostate cancer among difficult diagnostic cases. Urology. 2002;60:93-7.
10. Boccon-Gibod LM, et al. Prostate saturation biposy in the reevalation of microfocal prostate cancer. J Urol. 2006;176:961-3.
11. Ashley RA, et al. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2008;53(5):976-83.
12. Rosen RC, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822-30.
13. Cappelleri JC, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54:346-51.
14. Rosen RC, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res.1999. 1999 (11).
15. Barry MJ, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549-57.
16. Zisman A, et al. The impact of prostate biopsy on patient well-being: a prospective study of voiding impairment. J Urol. 2001;166:2242-6.
17. Zisman A, et al. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol. 2001;165(2):445-54.
18. Bozlu M, et al. Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity? Urology. 2003;62:1050-3.
19. Chrisofos M, et al. Can prostate biopsies affect erectile function? Andrologia. 2006;38(3):79-83.
20. Berger AP, et al. Periprostatic administration of local anesthesia during transrectal ultrasound-guided biopsy of the prostate: a randomized, double-blind, placebo-controlled study. Urology. 2003;61(3):585-8.
21. Öbek CAN, et al. Comparison of three different methods of anesthesia before transrectal prostate biopsy: a prospective randomized trial. J Urol. 2004;172(2):502-5.
22. Tuncel A, et al. The impact of transrectal prostate needle biopsy on sexuality in men and their female partners. Urology. 2008;71(6):1128-31.
23. Aktoz T, et al. Multimodal approach to management of prostate biopsy pain and effects on sexual function: efficacy of levobupivacaine adjuvant to diclofenac sodiujm - a prospective randomized trial. Andrologia. 2009;42:35-40.
24. • Klein T, et al. The impact of prostate biopsy and periprostatic nerve block on erectile and voiding function: a prospective study. J Urol. 2010;184(4):1447-52. This randomized trial found that prostate biopsy may cause urinary symptoms and erectile dysfunction, regardless of anesthesia or number of cores sampled.
25. Akyol I, Adayener C. Transient impotence after transrectal ultrasound-guided prostate biopsy. J Clin Ultrasound. 2008;36(1):33-4.
26. Akbal C, et al. Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy. Eur Urol. 2008;53(3):540-6.
27. Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011;29(27):3669-76.
28. Klotz L. Active surveillance for favorable-risk prostate cancer: background, patient selection, triggers for intervention, and outcomes. Curr Urol Rep. 2012;13(2):153-9.
29. • Fujita K, et al. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol. 2009;182(6):2664-9. This study demonstrated that men who undergo serial biopsies are at a higher risk for erectile dysfunction.
30. Dale W, et al. The role of anxiety in prostate carcinoma. Cancer. 2005;104(3):467-78.
31. Macefield RC, et al. Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Canc. 2010;102(9):1335-40.
32. Mehnert A, et al. Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Canc Care. 2010;19(6):736-45.
33. Sharpley CF, Christie DRH, Bitsika V. Variability in anxiety and depression over time following diagnosis in patients with prostate cancer. J Psychosoc Oncol. 2010;28(6):644-65.
34. Franco EL, et al. Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Medicine. 2009;6(12):e1000197.
35. Bill-Axelson A, et al. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from pcbase sweden. Eur Urol. 2010;57(3):390-5.
36. Fang F, et al. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the united states. J Natl Canc Inst. 2010;102(5):307-14.
37. Brindle LA, et al. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int. 2006;98(4):777-82.
38. • Helfand BT, et al. Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy. BJU Int. 2012. May 28. doi: 10.1111/j.1464-410X.2012.11268.x. [Epub ahead of print] This study found that men diagnosed with cancer had erectile dysfunction, while men with benign disease did not.
39. Hayes JH, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010;304(21):2373-80.
40. Burnet KL, et al. Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int. 2007;100(3):540-3.
41. van den Bergh RCN, et al. Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol. 2010;183(5):1786-91.
42. van den Bergh RCN, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer. 2009;115(17):3868-78.
43. Arredondo SA, et al. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2004;172(5):1830-4.
44. Vasarainen H, et al. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int. 2012;109(11):1614-9.
45. Goh AC, et al. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot stufy of men with prostate cancer who undergo active surveillance. BJU Int. 2011. Dec 7. doi: 10.1111/j.1464-410X.2011.10791.x. [Epub ahead of print].